Minicircle DNA biopharmaceuticals are more effective for therapeutic applications.
Robust technologies for minicircles detection and recovery are limited.
Novel zinc-histidine peptide exhibits high affinity towards minicircle DNA vectors.
The investigated biomimetic peptide represents a new ligand for DNA minicircles.
Metal-peptide complexes represent a new purification technology.